Review Article
Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review
Figure 4
Risk of bias. Review authors’ judgments about each risk of bias item for included studies.